Status:
COMPLETED
Prehabilitation for Pelvic Cancer: Changes in Setup Variability
Lead Sponsor:
University of Massachusetts, Worcester
Conditions:
Pelvic Cancer
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The investigators hypothesize that two pelvic relaxation exercises will be feasible and safe to perform by subjects daily before radiation during the participant's treatment and will decrease variabil...
Eligibility Criteria
Inclusion
- Patients will be \>21 yrs of age and will have an oncologic diagnosis that requires a course of pelvic radiation therapy for a minimum of 5 weeks.
- They will have an ECOG Performance Status (This scale, developed by the Eastern Cooperative Oncology Group (ECOG), now part of the ECOG-ACRIN (American College of Radiology Imaging Network) Cancer Research Group, describes a patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.)) of 1 or better as determined by patient history.
- They will be ambulatory without needing any ambulatory aids such as a cane or walker.
- Both men and women will be eligible as there is no significant anatomical difference in sacral slope measurement. Joint replacement patients will not be excluded.
Exclusion
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
- Non-English speaking subjects
Key Trial Info
Start Date :
June 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 17 2019
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03242538
Start Date
June 23 2017
End Date
January 17 2019
Last Update
September 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Massachusetts Medical School
Worcester, Massachusetts, United States, 01655